VIGANO', MAURO
 Distribuzione geografica
Continente #
NA - Nord America 406
EU - Europa 347
AS - Asia 177
AF - Africa 21
OC - Oceania 14
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
Totale 977
Nazione #
US - Stati Uniti d'America 390
IT - Italia 185
CN - Cina 72
DE - Germania 40
IN - India 27
GB - Regno Unito 24
FR - Francia 21
JP - Giappone 17
AU - Australia 14
IE - Irlanda 13
CA - Canada 10
HK - Hong Kong 8
RO - Romania 8
DK - Danimarca 7
EG - Egitto 7
ES - Italia 7
UA - Ucraina 7
CH - Svizzera 6
VN - Vietnam 6
BE - Belgio 5
ID - Indonesia 5
KR - Corea 5
TR - Turchia 5
AT - Austria 4
BR - Brasile 4
CG - Congo 4
CO - Colombia 4
CU - Cuba 4
IR - Iran 4
TW - Taiwan 4
FI - Finlandia 3
MM - Myanmar 3
MY - Malesia 3
NG - Nigeria 3
NL - Olanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
CL - Cile 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
EU - Europa 2
IQ - Iraq 2
MA - Marocco 2
NP - Nepal 2
PK - Pakistan 2
RS - Serbia 2
RU - Federazione Russa 2
TH - Thailandia 2
AL - Albania 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
CY - Cipro 1
DZ - Algeria 1
KH - Cambogia 1
LT - Lituania 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
PL - Polonia 1
PR - Porto Rico 1
SE - Svezia 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 979
Città #
Milan 106
Ashburn 40
Fairfield 33
Houston 30
Seattle 30
Woodbridge 23
Ann Arbor 17
Wilmington 15
Buffalo 14
Santa Cruz 14
Rome 13
Palermo 12
San Diego 12
Beijing 11
Shanghai 9
Sydney 8
Cambridge 7
Dublin 7
Indore 7
London 5
Norwalk 5
Bengaluru 4
Copenhagen 4
Dearborn 4
Hangzhou 4
Los Angeles 4
San Jose 4
Tokyo 4
Vienna 4
Wuhan 4
Brisbane 3
Cairo 3
Central District 3
Council Bluffs 3
Dong Ket 3
Guangzhou 3
Havana 3
Helsinki 3
Jeddah 3
Milpitas 3
Modena 3
Nürnberg 3
Ottawa 3
Southend 3
Toronto 3
University Park 3
Yangon 3
Ankara 2
Atibaia 2
Barcelona 2
Boardman 2
Bogotá 2
Brussels 2
Cajica 2
Chicago 2
Dallas 2
Delhi 2
Dhaka 2
Hinda 2
Jinan 2
Kathmandu 2
Kreuzlingen 2
Kudus 2
Kunming 2
Las Vegas 2
Lodi 2
Modigliana 2
Mountain View 2
Mumbai 2
Nanjing 2
New York 2
Nottingham 2
Palm 2
Paris 2
Perai 2
Phoenix 2
Porto 2
Redmond 2
San Francisco 2
Seoul 2
Sharjah 2
Sulaymaniyah 2
Suri 2
Taipei 2
Tampa 2
Toulouse 2
Turin 2
Wakefield 2
Aachen 1
Addis Ababa 1
Adelaide 1
Al Mansurah 1
Albany 1
Asahikawa 1
Auburn 1
Balestrate 1
Bangkok 1
Belgrade 1
Bhubaneswar 1
Bistriţa 1
Totale 599
Nome #
Clinical implications of HBsAg quantification in patients with chronic hepatitis B, file dfa8b98f-c572-748b-e053-3a05fe0a3a96 269
Real life experiences in HCV management in 2018, file dfa8b99e-6832-748b-e053-3a05fe0a3a96 228
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis, file dfa8b9a6-cb9a-748b-e053-3a05fe0a3a96 168
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies : two case reports, file dfa8b999-da1e-748b-e053-3a05fe0a3a96 132
Erythroid differentiation is suppressed by ribavirin during combination therapy with pegylated interferon-α2a in chronic hepatitis C: an in vitro and in vivo study, file dfa8b9a1-96ba-748b-e053-3a05fe0a3a96 131
Systematic review with meta-analysis : do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?, file dfa8b997-0f9e-748b-e053-3a05fe0a3a96 8
Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal, file dfa8b994-1a94-748b-e053-3a05fe0a3a96 6
Optimal therapy of chronic hepatitis B : how do I treat my HBeAg-negative patients?, file dfa8b996-e65c-748b-e053-3a05fe0a3a96 6
Results of treatment of chronic hepatitis B with pegylated interferon, file dfa8b997-4ccd-748b-e053-3a05fe0a3a96 6
Performance of Enhanced Liver Fibrosis test and comparison with transient elastography in the identification of liver fibrosis in patients with chronic hepatitis B infection, file dfa8b993-7701-748b-e053-3a05fe0a3a96 5
Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy, file dfa8b994-1f33-748b-e053-3a05fe0a3a96 5
Low risk of hepatitis B virus reactivation in HBsAg-negative/anti-HBc-positive carriers receiving rituximab for rheumatoid arthritis : a retrospective multicenter Italian study, file dfa8b995-83ef-748b-e053-3a05fe0a3a96 5
Treatment of hepatitis B : is there still a role for interferon?, file dfa8b99c-23d0-748b-e053-3a05fe0a3a96 5
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices : a 12-year prospective cohort study, file dfa8b996-cd2d-748b-e053-3a05fe0a3a96 4
HBeAg-negative chronic hepatitis B : why do I treat my patients with nucleos(t)ide analogues?, file dfa8b997-55d5-748b-e053-3a05fe0a3a96 4
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B, file dfa8b99c-41e3-748b-e053-3a05fe0a3a96 4
Concomitant therapy with direct-acting antivirals and chemoimmunotherapy in HCV-associated diffuse large B-cell lymphoma, file dfa8b99d-2a09-748b-e053-3a05fe0a3a96 4
Why do I treat HBeAg-negative chronic hepatitis B patients with pegylated interferon?, file dfa8b997-700c-748b-e053-3a05fe0a3a96 3
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients, file dfa8b99a-353e-748b-e053-3a05fe0a3a96 3
AISF position paper on HCV in immunocompromised patients, file dfa8b99e-81fd-748b-e053-3a05fe0a3a96 3
3 years of Adefovir and Lamivudine combination therapy minimized the risk of genotypic resistance to ADV in Lam resistant patients, file 294acc18-37a9-402e-b387-17e420ec9ada 2
Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H, file dfa8b990-6820-748b-e053-3a05fe0a3a96 2
Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs), file dfa8b998-b555-748b-e053-3a05fe0a3a96 2
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis, file dfa8b99d-0a6e-748b-e053-3a05fe0a3a96 2
Treatment of Hepatitis C virus infection in Italy : a consensus report from an expert panel, file dfa8b99e-0dbc-748b-e053-3a05fe0a3a96 2
The prognosis and management of inactive HBV carriers, file dfa8b997-116f-748b-e053-3a05fe0a3a96 1
Review article : The potential of interferon and nucleos(t)ide analogue combination therapy in chronic hepatitis B infection, file dfa8b997-3db9-748b-e053-3a05fe0a3a96 1
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma, file dfa8b99c-0ec5-748b-e053-3a05fe0a3a96 1
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease, file dfa8b99e-6483-748b-e053-3a05fe0a3a96 1
Totale 1.013
Categoria #
all - tutte 1.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 5 7 8
2019/2020104 4 1 6 15 9 8 11 7 11 13 12 7
2020/2021123 7 11 10 12 8 16 7 7 11 7 13 14
2021/2022187 8 9 7 27 28 7 15 10 13 19 32 12
2022/2023196 9 10 37 25 15 22 12 14 7 15 18 12
2023/2024166 12 23 24 12 20 9 21 12 17 16 0 0
Totale 1.013